BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 29278655)

  • 1. Eosinophilic esophagitis in Japan: Focus on response to acid suppressive therapy.
    Ishimura N; Kinoshita Y
    J Gastroenterol Hepatol; 2018 May; 33(5):1016-1022. PubMed ID: 29278655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
    Jiao D; Ishimura N; Maruyama R; Ishikawa N; Nagase M; Oshima N; Aimi M; Okimoto E; Mikami H; Izumi D; Okada M; Ishihara S; Kinoshita Y
    J Gastroenterol; 2017 Feb; 52(2):203-210. PubMed ID: 27108416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor-responsive esophageal eosinophilia: a historical perspective on a novel and evolving entity.
    Molina-Infante J; Katzka DA; Dellon ES
    Rev Esp Enferm Dig; 2015 Jan; 107(1):29-36. PubMed ID: 25603329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proton Pump Inhibitor-responsive Esophageal Eosinophilia: An Overview of Cases from One University Hospital Center].
    Ahn B; Lee DH; Lee CM; Hwang JJ; Yoon H; Shin CM; Park YS; Kim N
    Korean J Gastroenterol; 2016 Apr; 67(4):178-82. PubMed ID: 27112243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton-pump inhibitor-responsive esophageal eosinophilia.
    Molina-Infante J; Katzka DA
    Curr Opin Gastroenterol; 2014 Jul; 30(4):428-33. PubMed ID: 24837227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation.
    Wen T; Dellon ES; Moawad FJ; Furuta GT; Aceves SS; Rothenberg ME
    J Allergy Clin Immunol; 2015 Jan; 135(1):187-97. PubMed ID: 25441638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of proton pump inhibitor therapy in the management of eosinophilic esophagitis.
    Molina-Infante J; Prados-Manzano R; Gonzalez-Cordero PL
    Expert Rev Clin Immunol; 2016 Sep; 12(9):945-52. PubMed ID: 27097787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study.
    Dellon ES; Speck O; Woodward K; Gebhart JH; Madanick RD; Levinson S; Fritchie KJ; Woosley JT; Shaheen NJ
    Am J Gastroenterol; 2013 Dec; 108(12):1854-60. PubMed ID: 24145677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPI-responsive esophageal eosinophilia cannot be distinguished from eosinophilic esophagitis by endoscopic signs.
    Warners MJ; van Rhijn BD; Curvers WL; Smout AJ; Bredenoord AJ
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):506-11. PubMed ID: 25822858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study.
    Dellon ES; Speck O; Woodward K; Covey S; Rusin S; Gebhart JH; Chen X; Woosley JT; Shaheen NJ
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2015-22. PubMed ID: 24993367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences.
    Eluri S; Dellon ES
    Curr Opin Gastroenterol; 2015 Jul; 31(4):309-15. PubMed ID: 26039722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter study on the prevalence of eosinophilic esophagitis and PPI-responsive esophageal eosinophilic infiltration.
    Fujiwara Y; Sugawa T; Tanaka F; Tatsuwaki H; Okuyama M; Hayakawa T; Yamamori K; Wada R; Ohtani K; Uno H; Tanigawa T; Watanabe Y; Tominaga K; Watanabe T; Takaishi O; Saeki Y; Nebiki H; Oshitani N; Sato H; Arakawa T
    Intern Med; 2012; 51(23):3235-9. PubMed ID: 23207117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of eosinophilic esophagitis in clinical practice.
    Abe Y; Sasaki Y; Yagi M; Yaoita T; Nishise S; Ueno Y
    Clin J Gastroenterol; 2017 Apr; 10(2):87-102. PubMed ID: 28247277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis.
    Molina-Infante J; van Rhijn BD
    Best Pract Res Clin Gastroenterol; 2015 Oct; 29(5):749-758. PubMed ID: 26552774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oesophageal narrowing on barium oesophagram is more common in adult patients with eosinophilic oesophagitis than PPI-responsive oesophageal eosinophilia.
    Podboy A; Katzka DA; Enders F; Larson JJ; Geno D; Kryzer L; Alexander J
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1168-77. PubMed ID: 27028344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis.
    Molina-Infante J; Bredenoord AJ; Cheng E; Dellon ES; Furuta GT; Gupta SK; Hirano I; Katzka DA; Moawad FJ; Rothenberg ME; Schoepfer A; Spechler SJ; Wen T; Straumann A; Lucendo AJ;
    Gut; 2016 Mar; 65(3):524-31. PubMed ID: 26685124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.
    Moawad FJ; Schoepfer AM; Safroneeva E; Ally MR; Chen YJ; Maydonovitch CL; Wong RK
    Aliment Pharmacol Ther; 2014 Mar; 39(6):603-8. PubMed ID: 24461332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis.
    Mougey EB; Williams A; Coyne AJK; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Román E; González Lois C; Chao M; Al-Atrash H; Lima JJ; Franciosi JP
    J Pediatr Gastroenterol Nutr; 2019 Nov; 69(5):581-587. PubMed ID: 31490856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report of proton pump inhibitor responsive esophageal eosinophilia: why 2 months of proton pump inhibitors is required.
    Lipka S; Muhammad A; Champeaux A; Richter JE
    Dis Esophagus; 2016 Aug; 29(6):700-3. PubMed ID: 24842729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.